Funding Acknowledgements Type of funding sources: Public grant(s) – EU funding. Main funding source(s): Project no. RRF-2.3.1-21-2022-00004 (MILAB) has been implemented with the support provided by the European Union. Introduction Cardiopulmonary exercise testing (CPET)-derived peak oxygen uptake (VO2/kg) is a well-established parameter of exercise capacity allowing the quantification of athletic performance. Although VO2/kg is mainly influenced by anthropometric and demographic factors, several studies demonstrated strong associations between resting echocardiography-based measures and VO2/kg. Artificial intelligence could incorporate information from both features, thus enabling a more accurate prediction of exercise capacity in athletes. Aim Accordingly, we aimed to implement a deep-learning (DL) model that uses 2D echocardiography (2DE)-based apical 4-chamber view videos on top of the anthropometric features (age, sex, body surface area [BSA]) to predict VO2/kg and then assess the model’s performance in a large cohort of athletes. Methods We retrospectively identified 422 competitive athletes (15.4±7.3 training hours/week) who underwent resting 2DE evaluation and then CPET to determine VO2/kg (52.7 ± 7.7 mL/kg/min). To predict VO2/kg values, we trained a deep neural network that can process both modalities of the inputs (i.e. 2DE videos and anthropometric data such as age, sex and BSA) simultaneously (Figure 1). We applied 5-fold cross-validation and used mean squared error (MSE), mean absolute error (MAE), and R squared (R2) metrics to measure our model’s performance. Then, we compared the results with linear regression that was trained using only the 3 anthropometric factors (age, gender, BSA). Additionally, after finalization of the DL-based model, we prospectively recruited further 25 competitive athletes with both 2DE and CPET performed to validate our model. Results Using 2DE videos, our DL-based model was able to achieve an accurate prediction of VO2/kg with an MSE of 35.27, MAE of 4.62, and an R2 of 0.393. In comparison, the linear regression model using only anthropometric factors had worse predictive performance in all metrics with an MSE of 40.51, MAE of 4.88, and R2 of 0.303. In addition, we compared the predictive performance of the DL-based and the linear regression models by their respective squared error values using the Wilcoxon test. Our DL-based model had a significantly better performance compared to the linear regression model (Wilcoxon p = 0.006). In the prospective dataset, our DL-based model achieved an MSE of 16.69, MAE of 3.42, and an R2 of 0.169, whereas the linear regression model was inferior with an MSE of 25.43, MAE of 4.51, and an R2 of −0.268. The DL-based model showed a significantly better performance (Wilcoxon p<0.001). Conclusions Using our DL-based approach on our large athlete database, we were able to implement and prospectively validate a model that incorporated 2DE videos to predict VO2/kg more accurately compared to using anthropometric factors alone. DL techniques may advance sports medicine by personalized monitorization of training phases and accurate prediction of athletic performance.
Background: The effect of ALPPS on tumor proliferation, remains a concern. This study investigated the impact of ALPPS on growth of colorectal metastases in mice and human. Methods: The effect of ALPPS and 90% portal vein ligation (PVL) on colorectal liver and lung metastases was investigated in mice. In vivo tumor progression was assessed by magnetic resonance imaging (MRI), histology and survival experiments. The effects of ALPPS, PVL and control sera on colorectal cancer cells (MC38 and CT26) were tested in vitro. Additionally, the international ALPPS registry enabled to identify patients with remaining tumor in the future liver remnant (FLR) after ALPPS stage 1. Results: Two and three weeks after ALPPS stage 1, PVL or sham surgery, liver MRI showed similar intrahepatic tumor numbers ((p=0.14/0.82), sizes (p=0.45/0.98) and growth kinetics (p=0.58/0.68). Tumor growth was not different between ALPPS and PVL groups after completion of stage 2. Survival after tumor cell injection was similar after sham surgery and completion of ALPPS and PVL (36 days (IQR 32-40) vs. 42 days (IQR 36-48) vs. 39 days (IQR 35-42), p=0.237). Pulmonary metastases progression and in vitro cell proliferation were comparable among groups. Observations in humans failed to identify accelerated tumor growth in the FLR within the regenerative phase after ALPPS stage 1. Conclusion:The accelerated regeneration process associated to ALPPS does not enhance the growth of residual colorectal liver metastases.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.